All ingredient lists · Model report

Ingredient list

TB-500 (Thymosin β4 Acetate).

Declared composition for LIRAVEXIN catalog number BT20. This page lists what the catalog names. It is not a laboratory assay and not a test result.

Ingredient list — declared composition, not a test result
GS Laboratory

Prepared as a catalog companion to the model testing report.

Ingredient list

Declared composition for a LIRAVEXIN catalog item — not a tested result

Catalog number
BT20
Product name
TB-500 (Thymosin β4 Acetate)
Labelled amount
20 mg
Pack, as catalogued
20 mg × 10 vials
Physical form
Lyophilised powder in a vial
Catalog
LIRAVEXIN (www.liravexin.com)

Declared ingredients

Ingredient Amount as declared Public identity
TB-500 (Thymosin β4 Acetate)20 mgThe catalog label names this item as TB-500 (Thymosin β4 Acetate). In public use the name TB-500 is applied both to a short thymosin β4 fragment and to the full thymosin β4 peptide. Because the exact form is not uniquely fixed by the catalog name, no amino-acid sequence is stated here.
Other constituents—Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here.

Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.

Notes

This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.

The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.

Declared composition — not a test result · BT20